SETD1A and breast neoplasm: Different expression of both SET-1 and SET-2 delineated two groups: SET-1 over-expressing group [B] that included BRCA-related and sporadic breast tumors with and without TN phenotype and SET-2 over-expressing group [A], consisting mainly of sporadic NTNBCs.